The first issue 2017 in Advanced Materials Interfaces highlights “Perspectives in Interface Research”.
Tumor-Targeted Nanotherapeutics for Glioblastoma
In an effort to overcome barriers to the treatment of glioblastoma (GBM), targeted nanotherapeutics have emerged as promising drug delivery systems with the potential to improve pharmacokinetic profiles and therapeutic efficacy.
A Fresh Collection of Review Articles for the New Year
Macromolecular Journals – For a limited time you can now take a look at this article collection for free!
The Sound of Smallness
Researchers from the Massachusetts Institute of Technology, USA have introduced a simple strategy for making nanoparticles by the sonofragmentation of high‐aspect‐ratio 1D substrates.
Porous Silicon Nanovaccines Combat Cancer
Researchers from Finland and the USA, have developed two multistage nanovaccines constructed of two biomaterials and either a biological cancer cell membrane (CCM) or a model antigen
Manipulating Light with Magnetic Bacteria
Magnetic bacteria devices can manipulate light similar to liquid crystals in display and spatial light modulator technology.
Particle Micromotors
Magnetically steerable, acid-resistant micromotors are developed that can be fabricated by electrostatic attraction between magnetite nanoparticles and gold microrods at pH ≈ 4.
Particulate Delivery Systems for Vaccination against Bioterrorism Agents and Emerging Infectious Pathogens
Nano- and micro-particulate vaccine delivery systems minimize side effects, trigger targeted and robust immune responses, and protect and stabilize vaccine components
Cancer Immunotherapy and Nanotechnology: Taking the Best from Two Worlds
Researchers are applying nanotechnology to cancer immunotherapy toward the development of nanocarriers for delivery of cancer vaccines and chemo-immunotherapies.
Transition Metal Dichalcogenides: The Future of Bio-Applications of Two Dimensional Materials
The majority of the developed bio-systems based on 2D transition metal dichalcogenides are reviewed in Small.







